Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Purple Biotech is a biotechnology business based in the US. Purple Biotech shares (PPBT) are listed on the NASDAQ and all prices are listed in US Dollars. Purple Biotech employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $2.14 |
|---|---|
| 52-week range | $1.83 - $4.75 |
| 50-day moving average | $2.34 |
| 200-day moving average | $2.92 |
| Wall St. target price | $25.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.08 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.1401 from 2022-10-03
| 1 week (2022-09-27) | 12.64% |
|---|---|
| 1 month (2022-09-02) | -8.15% |
| 3 months (2022-07-01) | -1.38% |
| 6 months (2022-04-04) | -45.82% |
| 1 year (2021-10-04) | -50.92% |
|---|---|
| 2 years (2020-10-02) | -50.58% |
| 3 years (2019-10-04) | 2,780.35% |
| 5 years (2017-10-04) | 1,026.37% |
| Gross profit TTM | $-55,000 |
|---|---|
| Return on assets TTM | -16.9% |
| Return on equity TTM | -29.14% |
| Profit margin | 0% |
| Book value | $3.08 |
| Market capitalisation | $37.2 million |
TTM: trailing 12 months
We're not expecting Purple Biotech to pay a dividend over the next 12 months.
Purple Biotech's shares were split on a 1:10 basis on 21 August 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Purple Biotech shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Purple Biotech shares which in turn could have impacted Purple Biotech's share price.
Over the last 12 months, Purple Biotech's shares have ranged in value from as little as $1.833 up to $4.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Purple Biotech's is 1.976. This would suggest that Purple Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Purple Biotech Ltd. , a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer; and NT219, a small molecule that targets insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company is headquartered in Rehovot, Israel. .
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.